Outcomes in Children With Pre-operative Residual Hearing
NCT ID: NCT03379870
Last Updated: 2024-10-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2018-05-25
2023-12-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants: Two cohorts of CI recipients aged 6 through 17 years who had pre-operative low frequency residual hearing. Subjects in Arm 1 (EAS Arm; electric-acoustic stimulation) will present with a post-operative low frequency pure tone average (125, 250, and 500 Hz) of ≤ 75 dB HL, and those in Arm 2 (FES Arm; full-electric stimulation) will present with a post-operative low frequency pure tone average (LFPTA) that exceeds 75 dB HL.
Procedures (methods): Subjects will complete speech perception and quality of life testing during post-operative intervals. Subjects in the EAS Arm will be evaluated with combined electric-acoustic stimulation (EAS). Subjects in FES Arm will be evaluated with FES alone.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cochlear Implantation in Pediatric Cases of Unilateral Hearing Loss
NCT02963974
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
NCT04707885
Cochlear Implants in Post-lingually Children: Results After 10 Years
NCT01400178
Objective Measures in Cochlear Implant
NCT03260374
Development of Auditory Skills in Young Deaf Children With Bilateral Cochlear Implants
NCT00604474
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
While hearing preservation rates are good, they are not guaranteed. Children with progressive hearing loss may continue to lose hearing, even if they maintain some residual hearing immediately after surgery. As a secondary aim, the investigators intend to study outcomes in children who do not maintain residual hearing and are fit with traditional CI programming methods. Children with more residual hearing are being implanted, and this study design allows validation of outcomes in both populations.
Subject enrollment will occur on the initial stimulation date. Those who have maintained a low frequency hearing average of 75 dB HL or better will be fit with a SONNET EAS or SONNET 2 EAS device using combined acoustic and electric stimulation. Those who have not maintained low frequency hearing will be fit with a SONNET EAS or SONNET 2 EAS device using electric stimulation only. Subjects will be followed at regular intervals throughout the year duration of the study and will be tested on measures of speech understanding in quiet, speech understanding in noise, quality of life, and discrimination of prosody or pitch changes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EAS Arm
Subjects who receive a CI and present with a post-operative LFPTA of ≤ 75 dB HL.
Electric Acoustic Speech Processor: Electric-acoustic stimulation (EAS) fitting.
Electric Acoustic Speech Processor: Electric-acoustic stimulation fitting
Electric Acoustic Stimulation for children with post-operative residual low frequency hearing averages of 75 dB HL or better,
FES Arm
Subjects with pre-operative low frequency hearing who receive a CI and present with a post-operative LFPTA of \> 75 dB HL.
Electric Acoustic Speech Processor: Full-electric stimulation (FES) fitting
Electric Acoustic Speech Processor: Full-electric stimulation fitting
Electric Stimulation for children with post-operative residual low frequency hearing averages of 75 dB HL or poorer and pre-operative low frequency hearing averages of 75 dB HL or better.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electric Acoustic Speech Processor: Electric-acoustic stimulation fitting
Electric Acoustic Stimulation for children with post-operative residual low frequency hearing averages of 75 dB HL or better,
Electric Acoustic Speech Processor: Full-electric stimulation fitting
Electric Stimulation for children with post-operative residual low frequency hearing averages of 75 dB HL or poorer and pre-operative low frequency hearing averages of 75 dB HL or better.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Spoken English as the primary language (speech perception testing conducted in English).
* Recipient of a MED-EL SYNCHRONY Cochlear Implant device.
* Pre-operative LFPTA of ≤ 75 dB HL.
* Willing and able to participate in study procedures.
* Realistic parental/patient expectations.
* Language skills judged to be adequate enough to perform study tasks.
Exclusion Criteria
* Inability to perform test battery due to behavior or cognitive impairment
* Unwilling or unable to participate in study procedures.
* Cochlear nerve deficiency.
* Anatomical considerations that necessitated surgical modifications such as ossification, incomplete insertion, or placement in scala vestibuli.
60 Months
215 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Med-El Corporation
INDUSTRY
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa Park, AuD
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Children's Cochlear Implant Center at UNC
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-2360
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.